Cite

    Akanksha Sharma et al.. “Neuro-oncologists have spoken – the role of bevacizumab in the inpatient setting. A clinical and economic conundrum.” Neuro-oncology practice, vol. 6, no. 1, 2019, pp. 30–36. http://access.bl.uk/ark:/81055/vdc_100095203315.0x000007